Human enhancement technologies like CRISPR, brain implants, and AI are advancing rapidly, forcing society to confront ethical questions about equity, consent, and what it means to be human before irreversible changes reshape our species.
Invasive species threaten ecosystems worldwide, but humanity is fighting back with remarkable success. From biological control agents reducing invasive seeds by 98% to complete eradication programs on islands, we're developing sophisticated tools—eDNA detection, CRISPR gene editing, and community science networks—that prove we can restore damaged ecosystems.
Genetically engineered pig organs are now functioning in human patients for months after decades of failures, thanks to CRISPR technology that eliminates immune rejection triggers. FDA-approved trials signal the technology could solve organ shortages by 2030, though ethical, economic, and access challenges remain.
Scientists use CRISPR to resurrect traits from extinct species like mammoths and dire wolves, creating genetic hybrids. But billion-dollar de-extinction projects raise urgent questions: Should we resurrect the dead when living species need saving now?
Scientists are racing to resurrect extinct species using CRISPR gene editing, with the first woolly mammoth calf expected by 2028. While de-extinction offers conservation breakthroughs, it raises critical questions about ecology, ethics, and whether we should resurrect what we destroyed.
Loading featured articles...